Overview of Immunotherapy in Alzheimer's Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD

被引:16
作者
Counts, Scott E. [1 ]
Lahiri, Debomoy K. [2 ]
机构
[1] Michigan State Univ, Dept Family Med, Dep Translat Sci & Mol Med, Grand Rapids, MI 49503 USA
[2] Indiana Univ, Sch Med, Neurosci Res Ctr, Inst Psychiat Res,Dept Med & Mol Genet,Dept Psych, Indianapolis, IN 46202 USA
关键词
AMYLOID-BETA-PEPTIDE; MOUSE MODEL; INTRAVENOUS IMMUNOGLOBULINS; TAU PATHOLOGY; IMMUNIZATION; ANTIBODY; BRAIN; PRESERVES; TOXICITY; TRIALS;
D O I
10.2174/156720501107140815102453
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:623 / 625
页数:3
相关论文
共 31 条
[1]   Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles [J].
Castillo-Carranza, Diana L. ;
Sengupta, Urmi ;
Guerrero-Munoz, Marcos J. ;
Lasagna-Reeves, Cristian A. ;
Gerson, Julia E. ;
Singh, Gurpreet ;
Estes, D. Mark ;
Barrett, Alan D. T. ;
Dineley, Kelly T. ;
Jackson, George R. ;
Kayed, Rakez .
JOURNAL OF NEUROSCIENCE, 2014, 34 (12) :4260-4272
[2]   Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer's Disease [J].
Counts, Scott E. ;
Perez, Sylvia E. ;
He, Bin ;
Mufson, Elliott J. .
CURRENT ALZHEIMER RESEARCH, 2014, 11 (07) :655-663
[3]   Intravenous Immunoglobulin (IVIG) Treatment Exerts Antioxidant and Neuropreservatory Effects in Preclinical Models of Alzheimer's Disease [J].
Counts, Scott E. ;
Ray, Balmiki ;
Mufson, Elliott J. ;
Perez, Sylvia E. ;
He, Bin ;
Lahiri, Debomoy K. .
JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 :S80-S85
[4]   Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model [J].
Dodart, JC ;
Bales, KR ;
Gannon, KS ;
Greene, SJ ;
DeMattos, RB ;
Mathis, C ;
DeLong, CA ;
Wu, S ;
Wu, X ;
Holtzman, DM ;
Paul, SM .
NATURE NEUROSCIENCE, 2002, 5 (05) :452-457
[5]   Human antibodies against amyloid β peptide:: A potential treatment for Alzheimer's disease [J].
Dodel, R ;
Hampel, H ;
Depboylu, C ;
Lin, SZ ;
Gao, F ;
Shock, S ;
Jäckel, S ;
Wei, W ;
Buerger, K ;
Höft, C ;
Hemmer, B ;
Möller, HJ ;
Farlow, M ;
Oertel, WH ;
Sommer, N ;
Du, YS .
ANNALS OF NEUROLOGY, 2002, 52 (02) :253-256
[6]   Reduced levels of amyloid β-peptide antibody in Alzheimer disease [J].
Du, Y ;
Dodel, R ;
Hampel, H ;
Buerger, K ;
Lin, S ;
Eastwood, B ;
Bales, K ;
Gao, F ;
Moeller, HJ ;
Oertel, W ;
Farlow, M ;
Paul, S .
NEUROLOGY, 2001, 57 (05) :801-805
[7]   Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial [J].
Gilman, S ;
Koller, M ;
Black, RS ;
Jenkins, L ;
Griffith, SG ;
Fox, NC ;
Eisner, L ;
Kirby, L ;
Rovira, MB ;
Forette, F ;
Orgogozo, JM .
NEUROLOGY, 2005, 64 (09) :1553-1562
[8]   Role of Complement Systems in IVIG Mediated Attenuation of Cognitive Deterioration in Alzheimer's Disease [J].
Gong, Bing ;
Levine, Samara ;
Barnum, Scott R. ;
Pasinetti, Giulio M. .
CURRENT ALZHEIMER RESEARCH, 2014, 11 (07) :637-644
[9]  
Hughes RAC, 2009, CLIN EXP IMMUNOL, V158, P34, DOI [10.1111/j.1365-2249.2009.04025.X, 10.1111/j.1365-2249.2009.04025.x]
[10]   Intraventricular Human Immunoglobulin Distributes Extensively but Fails to Modify Amyloid in a Mouse Model of Amyloid Deposition [J].
Joly-Amado, Aurelie ;
Brownlow, Milene ;
Pierce, Jacob ;
Ravipati, Advaitaa ;
Showalter, Erin ;
Li, Qingyou ;
Gordon, Marcia N. ;
Morgan, Dave .
CURRENT ALZHEIMER RESEARCH, 2014, 11 (07) :664-671